These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study. Bae JM, Lee HH, Lee BI, Lee KM, Eun SH, Cho ML, Kim JS, Park JM, Cho YS, Lee IS, Kim SW, Choi H, Choi MG. Aliment Pharmacol Ther; 2018 Jul; 48(2):196-205. PubMed ID: 29869804 [Abstract] [Full Text] [Related]
3. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. Cheddani H, Dauchet L, Fumery M, Charpentier C, Marie Bouvier A, Dupas JL, Pariente B, Peyrin-Biroulet L, Savoye G, Gower-Rousseau C. Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308 [Abstract] [Full Text] [Related]
12. The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study. Agrawal M, Christensen HS, Bøgsted M, Colombel JF, Jess T, Allin KH. Gastroenterology; 2022 Dec 01; 163(6):1547-1554.e5. PubMed ID: 35952799 [Abstract] [Full Text] [Related]
14. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Burisch J. Dan Med J; 2014 Jan 01; 61(1):B4778. PubMed ID: 24393595 [Abstract] [Full Text] [Related]
15. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014. Kirchgesner J, Lemaitre M, Rudnichi A, Racine A, Zureik M, Carbonnel F, Dray-Spira R. Aliment Pharmacol Ther; 2017 Jan 01; 45(1):37-49. PubMed ID: 27781286 [Abstract] [Full Text] [Related]